DUBLIN--(BUSINESS WIRE)--Research and Markets (http://www.researchandmarkets.com/research/3cfzrf/progressive) has announced the addition of the "Progressive Supranuclear Palsy - Pipeline Review, H1 2013" report to their offering.
This report provides an overview of the indication's therapeutic pipeline. The analysis provides information on the therapeutic development for Progressive Supranuclear Palsy, complete with latest updates, and special features on late-stage and discontinued projects.
It also reviews key players involved in the therapeutic development for Progressive Supranuclear Palsy. The data is built using data and information sourced from proprietary databases, Company/University websites, SEC filings, investor presentations and featured press releases from company/university sites and industry-specific third party sources, put together by a team of experts.
- A snapshot of the global therapeutic scenario for Progressive Supranuclear Palsy.
- A review of the Progressive Supranuclear Palsyproducts under development by companies and universities/research institutes based on information derived from company and industry-specific sources.
- Coverage of products based on various stages of development ranging from discovery till registration stages.
- A feature on pipeline projects on the basis of monotherapy and combined therapeutics.
- Coverage of the Progressive Supranuclear Palsypipeline on the basis of route of administration and molecule type.
- Key discontinued pipeline projects.
- Latest news and deals relating to the products.
Key Topics Covered:
List of Tables
List of Figures
Progressive Supranuclear Palsy Overview
An Overview of Pipeline Products for Progressive Supranuclear Palsy
Progressive Supranuclear Palsy Therapeutics under Development by Companies
Mid Clinical Stage Products
Early Clinical Stage Products
Discovery and Pre-Clinical Stage Products
Progressive Supranuclear Palsy Therapeutics - Products under Development by Companies
Companies Involved in Progressive Supranuclear Palsy Therapeutics Development
Assessment by Monotherapy Products
Assessment by Route of Administration
Assessment by Molecule Type
Progressive Supranuclear Palsy Therapeutics - Drug Profile Updates
Progressive Supranuclear Palsy Therapeutics - Dormant Products
Progressive Supranuclear Palsy - Product Development Milestones
Featured News & Press Releases
For more information visit http://www.researchandmarkets.com/research/3cfzrf/progressive